Trial Profile
Oral Bioavailability, Pharmacokinetics and safety of single and multiple dose Tedizolid (IV/PO) in Healthy Chinese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Sep 2016
Price :
$35
*
At a glance
- Drugs Tedizolid (Primary) ; Tedizolid (Primary)
- Indications Gram-positive infections; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Adverse reactions; Pharmacokinetics
- 23 Oct 2015 New trial record
- 19 Sep 2015 Results presented at Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.